NDC 0469-1725 – Xtandi

Enzalutamide 40 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC0469-1725

Product details

Brand name
Xtandi
Generic name
enzalutamide
Labeler
Astellas Pharma US, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
NDA · NDA213674
Marketed since
August 4, 2020
Listing expires
December 31, 2027
Pharmacologic class
Androgen Receptor Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Xtandi →

Package NDC codes (1)

Package NDCDescriptionSince
0469-1725-56 sample1 BOTTLE in 1 CARTON (0469-1725-56) / 56 TABLET in 1 BOTTLEAug 4, 2020

Other Xtandi products